Updated December 4 at 6:25am
Biotechnology
38 results total, viewing 11 - 20
A top pharmaceutical lobbying group is launching an ad campaign to defend drugmakers that have been under fire for their pricing practices. more
Tivorsan Pharmaceuticals Inc. has received orphan drug designation from the U.S. Food and Drug Administration for a drug used in the treatment of Duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle degeneration and weakness. more
Life Wear Technologies LLC has acquired TriCalm’s line of anti-itch products from Cosmederm Bioscience Inc. of San Diego. more
Biotechnology drugmaker AbbVie Inc. filed a lawsuit seeking to block Amgen Inc. from selling a copy of the arthritis medicine Humira, its top seller. more
A Chinese drug manufacturer is investing $42 million in Nabsys, which recently completed a financial restructuring that allowed it to reopen in March after being out of business for nearly seven months. more
IlluminOss Medical Inc. said Monday that it has completed enrollment in its first U.S. clinical trial toward U.S. Food and Drug Administration approval of its IlluminOss System, a minimally invasive system to repair bone fractures. more
Alexion Pharmaceuticals Inc. this morning hosted a groundbreaking ceremony for an expansion that is expected to double the size of its plant over the next five years. more
Ximedica, a medical-technology-development company, has acquired Accel Biotech based in Los Gatos, Calif. more
The University of Massachusetts was granted 62 utility patents in 2015, putting the school at No. 30 on a list of the Top 100 worldwide universities that were granted U.S. patents. more
(Updated, 6:15 p.m.) Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC. more
« Prev | 1 | 2 | 3 | 4 Next »